Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Experience

A fine
balance

>Berkshire Grey

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Turo

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

Michael Gilroy: The death of the SaaS LTV/CAC

LTV/CAC calculations are of waning importance in SaaS. It's clear to the SaaS community that the future of selling software is bottoms-up.
Highlight

The New York Times: The new sobriety

“We weren’t interested in making another bubbly water... We wanted to feel more, not less — to wake up fresh and ready to take on the day, in full...
Highlight

The New York Times: Cool nonalcoholic drinks for your sober summer

O.K., it’s nonalcoholic. But that does translate to buzz-free? Kin takes sober cocktails perhaps as far as they can go by blending botanicals...
Highlight

FierceBiotech: Canaan-backed Comet uncloaks with $28.5M and biopharma vet De Graaf at the helm

Comet Therapeutics, a biotech taking aim at metabolic diseases, has unveiled itself with $28.5 million in series A financing and biopharma veteran...